medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2014, Number 02

<< Back

Ginecol Obstet Mex 2014; 82 (02)

Functionality and endometrial changes associated with induction ovulation with citrate of clomifene and recombinant FSH in infertile women

Valdez-Morales FJ, Vital-Reyes VS, Hinojosa-Cruz JC, Cerbón M

Language: Spanish
References: 41
Page: 143-153
PDF size: 833.65 Kb.


ABSTRACT

It has been reported that infertility affects approximately 20% of couples in reproductive age around the world. Although many factors involved, ovulatory dysfunction and particularly the hypothalamus pituitary dysfunction are quite common. The first line treatment for these pathologies consists on the administration of inducing ovulation agents such as recombinant gonadotropins and clomiphene citrate which it was obtained high rates of ovulation but not of pregnancy. So determine the effect of these treatments on the endometrium at morphological and molecular level is very important to understand the female reproductive physiology and optimize clinical strategies to obtain better pregnancy rates after treatments. In this paper we detailed the studies that have reported changes at the molecular and morphological level in human endometrium.


REFERENCES

  1. Beier HM, Beier-Hellwig K, Sterzik K. The implantation receptive luteal phase of the endometrium. On the current status of molecular and cell biology research. Zentralbl Gynakol 2001;123:319-27.

  2. Hughes EG. The effectiveness of ovulation induction and intrauterine insemination in the treatment of persistent infertility: a meta-analysis. Hum Reprod 1997;12:1865-72.

  3. Homburg R. Clomiphene citrate--end of an era? A minireview. Hum Reprod 2005;20:2043-51.

  4. Denker HW. Implantation: a cell biological paradox. J Exp Zool 1993;266:541-58.

  5. Tabibzadeh S. Molecular control of the implantation window. Hum Reprod Update 1998;4:465-71.

  6. Aplin JD. The cell biological basis of human implantation. Baillieres Best Pract Res Clin Obstet Gynaecol 2000;14:757-64.

  7. Achache H, Revel A. Endometrial receptivity markers, the journey to successful embryo implantation. Hum Reprod Update 2006;12:731-46.

  8. Gargett CE, Chan RW, Schwab KE. Hormone and growth factor signaling in endometrial renewal: role of stem/ progenitor cells. Mol Cell Endocrinol 2008;288:22-9.

  9. Gargett CE, Healy DL. Generating receptive endometrium in Asherman’s syndrome. J Hum Reprod Sci 2011;4:49-52.

  10. Karges B, Karges W, de Roux N. Clinical and molecular genetics of the human GnRH receptor. Hum Reprod Update 2003;9:523-30.

  11. Cheng CK, Leung PC. Molecular biology of gonadotropinreleasing hormone (GnRH)-I, GnRH-II, and their receptors in humans. Endocr Rev 2005;26:283-306.

  12. Richards JS, Pangas SA. The ovary: basic biology and clinical implications. J Clin Invest 2010;120:963-72.

  13. Matzuk MM, Lamb DJ. The biology of infertility: research advances and clinical challenges. Nat Med 2008;14:1197- 213.

  14. Hawkins SM, Matzuk MM. The menstrual cycle: basic biology. Ann N Y Acad Sci 2008;1135:10-8.

  15. Fritz MA, Holmes RT, Keenan EJ. Effect of clomiphene citrate treatment on endometrial estrogen and progesterone receptor induction in women. Am J Obstet Gynecol 1991;165:177-85.

  16. Sereepapong W, Suwajanakorn S, Triratanachat S, Sampatanukul P, Pruksananonda K, Boonkasemsanti W, et al. Effects of clomiphene citrate on the endometrium of regularly cycling women. Fertil Steril 2000;73:287-91.

  17. Triwitayakorn A, Suwajanakorn S, Triratanachat S, Sampatanukul P, Pruksananonda K, Sereepapong W. Effects of initiation day of clomiphene citrate on the endometrium of women with regular menstrual cycles. Fertil Steril 2002;78:102-7.

  18. Amita M, Takahashi T, Tsutsumi S, Ohta T, Takata K, Henmi N et al. Molecular mechanism of the inhibition of estradiol-induced endometrial epithelial cell proliferation by clomiphene citrate. Endocrinology 2010;151:394-405.

  19. Li TC, Warren MA, Murphy C, Sargeant S, Cooke ID. A prospective, randomised, cross-over study comparing the effects of clomiphene citrate and cyclofenil on endometrial morphology in the luteal phase of normal, fertile women. Br J Obstet Gynaecol 1992;99:1008-13.

  20. Massai MR, Bergeron C, Martel D, de Ziegler D, Meduri G, Psychoyos A et al. Physiological oestradiol and progesterone replacement cycles in women with ovarian failure: a model to study endometrial maturation and sex steroid receptor regulation by exogenous hormones. Hum Reprod 1993;8:1828-34.

  21. Birkenfeld A, Beier HM, Schenker JG. The effect of clomiphene citrate on early embryonic development, endometrium and implantation. Hum Reprod 1986;1:387-95.

  22. Cheung W NE, Ho PC. A randomized double-blind comparison of perifollicular vascularity and endometrial receptivity in ovulatory women taking clomiphene citrate at two different times. Hum Reprod 2002;17:2881-4.

  23. Ozdemir I, Ustundag N, Guven A, Duran B, Demirci F. Effect of clomiphene citrate on ovarian, endometrial, and cervical histologies in a rat model. Gynecol Obstet Invest 2005;60:181-5.

  24. Dahmoun M, Boman K, Cajander S, Westin P, Backstrom T. Apoptosis, proliferation, and sex hormone receptors in superficial parts of human endometrium at the end of the secretory phase. J Clin Endocrinol Metab 1999;84:1737-43.

  25. Shiozawa T LS, Nakayama K, Nikaido T, Fujii S. Relationship between the expression of cyclins/cyclin-dependent kinases and sex-steroid receptors/Ki67 in normal human endometrial glands and stroma during the menstrual cycle. Mol Hum Reprod 1996;2:745-52.

  26. Vaskivuo TE, Stenback F, Karhumaa P, Risteli J, Dunkel L, Tapanainen JS. Apoptosis and apoptosis-related proteins in human endometrium. Mol Cell Endocrinol 2000;165:75-83.

  27. Mertens HJ, Heineman MJ, Evers JL. The expression of apoptosis-related proteins Bcl-2 and Ki67 in endometrium of ovulatory menstrual cycles. Gynecol Obstet Invest 2002;53:224-30.

  28. Bessmertnaia VS, Samoilov MV, Serebrennikova KG, Babichenko, II. [Endometrial morphological and immunohistochemical features in females with primary and secondary infertility]. Arkh Patol 2008;70:31-4.

  29. Valdez-Morales FJ, Gamboa-Dominguez A, Vital-Reyes VS, Hinojosa-Cruz JC, Mendoza-Rodriguez CA, Garcia-Carranca A et al. Differential expression of functionality markers in mid-secretory endometrium of infertile women under treatment with ovulation-inducing agents. Eur J Obstet Gynecol Reprod Biol 2013.

  30. Kokawa K, Shikone T, Nakano R. Apoptosis in the human uterine endometrium during the menstrual cycle. J Clin Endocrinol Metab 1996;81:4144-7.

  31. Jones RK, Searle RF, Bulmer JN. Apoptosis and bcl-2 expression in normal human endometrium, endometriosis and adenomyosis. Hum Reprod 1998;13:3496-502.

  32. Edwards DP. Regulation of signal transduction pathways by estrogen and progesterone. Annu Rev Physiol 2005;67:335-76.

  33. Dawood MY, Lau M, Khan-Dawood FS. Localization and expression of oxytocin receptor and its messenger ribonucleic acid in peri-implantation phase human endometrium during control and clomiphene-treated cycles. Am J Obstet Gynecol 1999;181:50-6.

  34. Howles CM, Alam V, Tredway D, Homburg R, Warne DW. Factors related to successful ovulation induction in patients with WHO group II anovulatory infertility. Reprod Biomed Online 2010;20:182-90.

  35. Olijve W, de Boer W, Mulders JW, van Wezenbeek PM. Molecular biology and biochemistry of human recombinant follicle stimulating hormone (Puregon). Mol Hum Reprod 1996;2:371-82.

  36. Ku SY, Choi YM, Suh CS, Kim SH, Kim JG, Moon SY et al. Effect of gonadotropins on human endometrial stromal cell proliferation in vitro. Arch Gynecol Obstet 2002;266:223-8.

  37. Canda MT, Kucuk M, Bagriyanik HA, Ozyurt D, Canda T. The only effects of recombinant follicle-stimulating hormone for ovulation induction in the pre-implantation period of rats. Arch Gynecol Obstet 2007;275:99-105.

  38. Barker MA, Boehnlein LM, Kovacs P, Lindheim SR. Follicular and luteal phase endometrial thickness and echogenic pattern and pregnancy outcome in oocyte donation cycles. J Assist Reprod Genet 2009;26:243-9.

  39. Vani S, McDonald SE, Williams AR, Mason JI, Thong KJ, Critchley HO. Mid-luteal endometrial intracrinology following controlled ovarian hyperstimulation involving use of a gonadotrophin releasing hormone antagonist. Hum Reprod 2007;22:2981-91.

  40. Blockeel C, Baumgarten M, De Vos M, Verheyen G, Devroey P. Administration of GnRH antagonists in case of elevated progesterone at initiation of the cycle: a prospective cohort study. Curr Pharm Biotechnol 2011;12:423-8.

  41. Sendag F, Akdogan A, Ozbilgin K, Giray G, Oztekin K. Effect of ovarian stimulation with human menopausal gonadotropin and recombinant follicle stimulating hormone on the expression of integrins alpha3, beta1 in the rat endometrium during the implantation period. Eur J Obstet Gynecol Reprod Biol 2010;150:57-60.




2020     |     www.medigraphic.com